ArticleBioengineering (Basel, Switzerland)2023
Enhancing Skin Cancer Detection and Classification in Dermoscopic Images through Concatenated MobileNetV2 and Xception Models.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- MorphoNet: An Interpretable Hierarchical Deep Learning Framework for Multi-Class Skin Lesion Classification Using Dermoscopic Morphology.Bioengineering (Basel, Switzerland) · 2026Article
- Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice.British journal of clinical pharmacology · 2026Review
- A robust stacked ensemble strategy with multi-optimizer CNN models for skin cancer classification.Scientific reports · 2026Article
- Article
- Explainable Deep Learning Framework for Binary Corrosion Image Classification Using Grad-CAM.Sensors (Basel, Switzerland) · 2025Article
- Enhanced skin cancer classification using modified efficientNetV2L with adaptive early stopping mechanism.Scientific reports · 2025Article
- Advanced skin cancer prediction with medical image data using MobileNetV2 deep learning and optimized techniques.Scientific reports · 2025Article
- LightweightUNet: Multimodal Deep Learning with GAN-Augmented Imaging Data for Efficient Breast Cancer Detection.Bioengineering (Basel, Switzerland) · 2025Article
- Multi-scale feature fusion of deep convolutional neural networks on cancerous tumor detection and classification using biomedical images.Scientific reports · 2025Article
- A precise model for skin cancer diagnosis using hybrid U-Net and improved MobileNet-V3 with hyperparameters optimization.Scientific reports · 2024Article
- AI in dermatology: a comprehensive review into skin cancer detection.PeerJ. Computer science · 2024Article
- Bio-Inspired Spotted Hyena Optimizer with Deep Convolutional Neural Network-Based Automated Food Image Classification.Biomimetics (Basel, Switzerland) · 2023Article
- NeuroMorphFusion: A Neuro-Inspired Hybrid Learning Framework for Interpretable Deep Lesion Detection in IoT-Enabled Healthcare Systems.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the most promising research initiatives in the healthcare field is focused on the rising incidence of skin cancer worldwide and improving early discovery methods for the disease. The most significant factor in the fatalities caused by skin cancer is the late identification of the disease. The likelihood of human survival may be significantly improved by performing an early diagnosis followed by appropriate therapy. It is not a simple process to extract the elements from the photographs of the tumors that may be used for the prospective identification of skin cancer. Several deep learning models are widely used to extract efficient features for a skin cancer diagnosis; nevertheless, the literature demonstrates that there is still room for additional improvements in various performance metrics. This study proposes a hybrid deep convolutional neural network architecture for identifying skin cancer by adding two main heuristics. These include Xception and MobileNetV2 models. Data augmentation was introduced to balance the dataset, and the transfer learning technique was utilized to resolve the challenges of the absence of labeled datasets. It has been detected that the suggested method of employing Xception in conjunction with MobileNetV2 attains the most excellent performance, particularly concerning the dataset that was evaluated: specifically, it produced 97.56% accuracy, 97.00% area under the curve, 100% sensitivity, 93.33% precision, 96.55% F1 score, and 0.0370 false favorable rates. This research has implications for clinical practice and public health, offering a valuable tool for dermatologists and healthcare professionals in their fight against skin cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.